Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 157-168

  Arnold, Steven E ^a   Louneva, Natalia ^a   Cao, Kajia ^a   Wang, Li San ^a   Han, Li Ying ^a   Wolk, David A ^a   Negash, Selamawit ^a   Leurgans, Sue E ^b   Schneider, Julie A ^b   Buchman, Aron S ^b   Wilson, Robert S ^b   Bennett, David A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibody microarray; Cognitive reserve; Glial fibrillary acidic protein; Synapse; Synaptophysin; Synaptopodin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; SYNAPTOPHYSIN; SYNAPTOPODIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BIOCHEMICAL COMPOSITION; CELL DENSITY; CELL LABELING; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SYNAPTOSOME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROTEIN ARRAY ANALYSIS; SYNAPSES; TAU PROTEINS;

EID: 84868099498     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.03.004     Document Type: Article

References (59)

1. Alvarez V.A., Sabatini B.L. Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci 2007, 30:79-97.
2. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edition 2000, American Psychiatric Association, American Psychiatric Association, Washington, DC.
3. Anderson K., Potter A., Baban D., Davies K.E. Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain 2003, 126:2052-2064.
4. Arendt T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 2009, 118:167-179.
5. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1991, 1:103-116.
6. Arvanitakis Z., Leurgans S.E., Barnes L.L., Bennett D.A., Schneider J.A. Microinfarct pathology, dementia, and cognitive systems. Stroke 2011, 42:722-727.
7. Baloyannis S.J. Dendritic pathology in Alzheimer's disease. J. Neurol. Sci 2009, 283:153-157.
8. Beach T.G., Kuo Y.M., Spiegel K., Emmerling M.R., Sue L.I., Kokjohn K., Roher A.E. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J. Neuropathol. Exp. Neurol 2000, 59:308-313.
9. Bennett D.A. Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project. Alzheimer Dis. Assoc. Disord 2006, 20(Suppl 2):S63-S68.
10. Bennett D.A., Schneider J.A., Aggarwal N.T., Arvanitakis Z., Shah R.C., Kelly J.F., Fox J.H., Cochran E.J., Arends D., Treinkman A.D., Wilson R.S. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006, 27:169-176.
11. Bennett D.A., Schneider J.A., Arvanitakis Z., Kelly J.F., Aggarwal N.T., Shah R.C., Wilson R.S. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006, 66:1837-1844.
12. Bennett D.A., Schneider J.A., Wilson R.S., Bienias J.L., Arnold S.E. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol 2004, 61:378-384.
13. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., Bach J. Natural history of mild cognitive impairment in older persons. Neurology 2002, 59:198-205.
14. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16:271-278. discussion 278-284.
15. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic. Biol. Med 2010, 48:1570-1576.
16. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., Mufson E.J. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol 2002, 51:145-155.
17. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.H., Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 1992, 13:179-189.
18. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14863-14868.
19. Ewbank D.C., Arnold S.E. Cool with plaques and tangles [editorial]. N Engl J. Med 2009, 360:2357-2359.
20. Haroutunian V., Schnaider-Beeri M., Schmeidler J., Wysocki M., Purohit D.P., Perl D.P., Libow L.S., Lesser G.T., Maroukian M., Grossman H.T. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch. Neurol 2008, 65:1211-1217.
21. Hatjiharissi E., Ngo H., Leontovich A.A., Leleu X., Timm M., Melhem M., George D., Lu G., Ghobrial J., Alsayed Y., Zeismer S., Cabanela M., Nehme A., Jia X., Moreau A.S., Treon S.P., Fonseca R., Gertz M.A., Anderson K.C., Witzig T.E., Ghobrial I.M. Proteomic analysis of Waldenstrom macroglobulinemia. Cancer Res 2007, 67:3777-3784.
22. Hubbard B.M., Fenton G.W., Anderson J.M. A quantitative histological study of early clinical and preclinical Alzheimer's disease. Neuropathol. Appl. Neurobiol 1990, 16:111-121.
23. Hyman B.T., Trojanowski J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol 1997, 56:1095-1097.
24. Iacono D., Markesbery W.R., Gross M., Pletnikova O., Rudow G., Zandi P., Troncoso J.C. The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 2009, 73:665-673.
25. Iacono D., O'Brien R., Resnick S.M., Zonderman A.B., Pletnikova O., Rudow G., An Y., West M.J., Crain B., Troncoso J.C. Neuronal hypertrophy in asymptomatic Alzheimer disease. J. Neuropathol. Exp. Neurol 2008, 67:578-589.
26. Iqbal K., Liu F., Gong C.X., Alonso Adel C., Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009, 118:53-69.
27. Jellinger K.A. Recent advances in our understanding of neurodegeneration. J. Neural Transm 2009, 116:1111-1162.
28. Lovell M.A., Soman S., Bradley M.A. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech. Ageing Dev 2011, 132:443-448.
29. Lyubartseva G., Smith J.L., Markesbery W.R., Lovell M.A. Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain. Brain Pathol 2010, 20:343-350.
30. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
31. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IIStandardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
32. Mitchell J.C., Perkinton M.S., Yates D.M., Lau K.F., Rogelj B., Miller C.C., McLoughlin D.M. Expression of the neuronal adaptor protein X11alpha protects against memory dysfunction in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis 2010, 20:31-36.
33. Mitchell T.W., Nissanov J., Han L.Y., Mufson E.J., Schneider J.A., Cochran E.J., Bennett D.A., Lee V.M., Trojanowski J.Q., Arnold S.E. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J. Histochem. Cytochem 2000, 48:1627-1638.
34. Mochizuki A., Peterson J.W., Mufson E.J., Trapp B.D. Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density. Exp. Neurol 1996, 142:89-102.
35. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., Kordower J.H. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol 1999, 158:469-490.
36. O'Brien R.J., Resnick S.M., Zonderman A.B., Ferrucci L., Crain B.J., Pletnikova O., Rudow G., Iacono D., Riudavets M.A., Driscoll I., Price D.L., Martin L.J., Troncoso J.C. Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J. Alzheimers Dis 2009, 18:665-675.
37. Petersen R.C., Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008, 13:45-53.
38. Price J.L., McKeel D.W., Buckles V.D., Roe C.M., Xiong C., Grundman M., Hansen L.A., Petersen R.C., Parisi J.E., Dickson D.W., Smith C.D., Davis D.G., Schmitt F.A., Markesbery W.R., Kaye J., Kurlan R., Hulette C., Kurland B.F., Higdon R., Kukull W., Morris J.C. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 2009, 30:1026-1036.
39. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol 1999, 45:358-368.
40. Reddy P.H., Mani G., Park B.S., Jacques J., Murdoch G., Whetsell W., Kaye J., Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J. Alzheimers Dis 2005, 7:103.
41. Riudavets M.A., Iacono D., Resnick S.M., O'Brien R., Zonderman A.B., Martin L.J., Rudow G., Pletnikova O., Troncoso J.C. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol. Aging 2007, 28:1484-1492.
42. Saldanha A.J. Java TreeView-extensible visualization of microarray data. Bioinformatics 2004, 20:3246-3248.
43. Savva G.M., Wharton S.B., Ince P.G., Forster G., Matthews F.E., Brayne C. Age, neuropathology, and dementia. N Engl J. Med 2009, 360:2302-2309. Medical Research Council Cognitive Function and Ageing Study.
44. Scales T.M., Derkinderen P., Leung K.Y., Byers H.L., Ward M.A., Price C., Bird I.N., Perera T., Kellie S., Williamson R., Anderton B.H., Reynolds C.H. Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn. Mol. Neurodegener 2011, 6:12.
45. Schmitt F.A., Davis D.G., Wekstein D.R., Smith C.D., Ashford J.W., Markesbery W.R. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology 2000, 55:370-376.
46. Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007, 69:2197-2204.
47. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (Eds.).
48. Soetanto A., Wilson R.S., Talbot K., Un A., Schneider J.A., Sobiesk M., Kelly J., Leurgans S., Bennett D.A., Arnold S.E. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch. Gen. Psychiatry 2010, 67:448-457.
49. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
50. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol 1997, 56:933-944.
51. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol 1991, 30:572-580.
52. Tomlinson B.E., Blessed G., Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci 1968, 7:331-356.
53. Tyas S.L., Salazar J.C., Snowdon D.A., Desrosiers M.F., Riley K.P., Mendiondo M.S., Kryscio R.J. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am. J. Epidemiol 2007, 165:1231-1238.
54. Weiner M.W., Veitch D.P., Aisen P.S., Beckett L.A., Cairns N.J., Green R.C., Harvey D., Jack C.R., Jagust W., Liu E., Morris J.C., Petersen R.C., Saykin A.J., Schmidt M.E., Shaw L., Siuciak J.A., Soares H., Toga A.W., Trojanowski J.Q. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 2012, 8(Suppl 1):S1-S68. Alzheimer's Disease Neuroimaging Initiative.
55. West M.J., Kawas C.H., Stewart W.F., Rudow G.L., Troncoso J.C. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging 2004, 25:1205-1212.
56. White L. Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia Aging Study. J. Alzheimers Dis 2009, 18:713-725.
57. Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Religious Orders Study: overview and change in cognitive and motor speed. Aging. Neuropschol. Cogn 2004, 2004:280-303.
58. Wilson R.S., Mendes De Leon C.F., Barnes L.L., Schneider J.A., Bienias J.L., Evans D.A., Bennett D.A. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002, 287:742-748.
59. Yang Y.H., Paquet A., Dudoit S. marray: exploratory analysis for two-color spotted microarray data. R package version 1.30 http://www.bioconductor.org/packages/release/bioc/html/marray.html.